Investigating the Pattern of Direct Medical Costs of Covid-19 Patients in Hospitals of Ilam Province

Abstract

Direct medical costs are the most well-known category of disease costs. This study aimed to investigate and analyze the direct medical costs of patients with Covid19 by services provided in the centers and hospitals affiliated to Ilam University of Medical Sciences. This study was a descriptive-analytical cross-sectional study using hospital costs information in Ilam province from March 2019 to September 2021. Financial information related to all patients diagnosed with Covid-19 disease was collected in all hospitals of the province and classified and reviewed using Excel 2016 software. In general, 1713711 services were provided in medical centers affiliated to Ilam University of Medical Sciences. Most of these services were provided in Shahid Mostafa Khomeini Educational and Medical Center as the main medical center for patients with Covid-19 in Ilam. The results of the study showed that among the direct medical costs, medication services (30%), laboratory (16%) and inpatient care (11%), were the highest costs in Ilam University of Medical Sciences. In total, out of the total direct medical costs, the share of patient's payments was 10%. The share of insurance companies in total expenditures was 83% and the share of government subsidy was 7%. Examining the pattern of drug consumption and pharmaceutical services can be considered as one of the key sectors by health policy makers in Ilam province, because the 30% share of pharmaceutical expenditures showed that the management of these services greatly control the medical expenditures of

Regulating the Rational Use of Antimicrobial Drugs and Improving the Quality of Healthcare Big Data: A Development and Usability Study as A Prelude to AI Assisted Healthcare

“…HIS system is the core component of hospital information construction, which realizes information sharing and collaborative work within the hospital by integrating various hospital departments and business processes, and is the source of healthcare big data [9].When using big data technology to manage and monitor the use of antimicrobial drugs, data quality is crucial, and "high-quality" data (meaning highly accurate and complete data) is a prerequisite for the effective analysis and application of medical big data, however, there are many factors affecting the quality of the data in reality [10][11][12][13], such as the level of knowledge and skills of healthcare personnel, the process of data collection and entry, and the methods of data statistics, analysis, and application.…”